By invitation only – the case for breast cancer screening reminders for women over 69 years
© Saunders et al; licensee BioMed Central Ltd. 2008
Received: 14 February 2008
Accepted: 06 November 2008
Published: 06 November 2008
Breast cancer is the leading cause of cancer death in women in Australia. Early detection provides the best chance of reducing mortality and morbidity from the disease. Mammographic screening is a population health strategy for the early detection of breast cancer in Australia. Recruitment strategies such as regular advertising and biannual screening invitations are exclusively targeted at women aged 50 – 69 years. Even though they can participate, women 70 years or over are not invited or actively encouraged to undertake screening. Research has found that a routine letter of invitation increases the number of women participating in breast cancer screening.
Cancer data analysis and a literature and policy review was conducted to assess age specific breast cancer mortality rates and the legitimacy of rationale used to limit invitations for breast cancer screening to women younger than 70 years.
The proportion of women over 69 years participating in the BreastScreen program is significantly less than rate of screening in the target age range (50–69 years). Evidence and data indicate that common justifications for limiting screening reminders to the target age range including life expectancy, comorbidities, effectiveness, treatment and cost are, for many women, unreasonable.
There is now sufficient data to support a change in the targeted upper age range for breast cancer screening to improve the existing suboptimal surveillance in women aged over 69 years.
Breast cancer is the most common invasive cancer diagnosed in females in Australia and is the leading cause of cancer death in this group . Age is the most important single risk factor for disease development and death rates increase consistently with advancing age . In 2005, the death rate per 100,000 for women aged 40–44 years was 17.0 increasing to 66 per 100,000 in women aged 65–69 years and escalating to 182.0 deaths per 100,000 in women aged 85 years or over . The annual number of years of potential life lost due to female breast cancer in Australia is over 32,000 . Long life expectancy is regarded as an indicator of a successful society and an effective health care system .
Mammography has been demonstrated to reduce morbidity and mortality from breast cancer  through early disease detection, which, when managed effectively, leads to improved survival and less aggressive treatment . At this time, mammography is the only accepted screening modality for breast cancer in average risk populations .
BreastScreen Australia is the national breast cancer screening program offering free mammography screening to asymptomatic women since 1991. A clear upper age limit has not been set for breast cancer screening in Australia; however, recruitment strategies are specifically targeted at women aged 50 – 69 years who are reminded to have a mammogram every two years via written invitations . Women aged 40–49 and 70 years or over are not invited for screening, although they are able to participate . Research has found that a routine letter of invitation increases the number of women participating in breast cancer screening [8, 9].
An examination of recent national cancer data was undertaken to assess age specific breast cancer mortality rates and a literature and policy review was conducted to assess the legitimacy of rationale used to limit invitations for breast cancer screening to women younger than 70 years of age.
One reason given for targeting women 50–69 years for screening is that early detection in this age group offers women "a better chance of successful treatment and recovery" presumably, because of a higher likelihood of comorbid conditions, reduced treatment tolerance and shorter life expectancy in women above 69 years . Another reason given is that most of the research showing mammographic screening effectiveness was conducted with women aged 50–69 years . The national BreastScreen policy states that the age for screening will be "monitored and reviewed as new data become available" . A program review is currently underway to assess the appropriateness of the existing BreastScreen Australia targeted age range .
In the past, elderly women have been significantly underrepresented in the evidence base used to determine the effectiveness of mammography. Researchers used age limits in recruitment as cut off points to minimise potential problems caused by comorbid health conditions and the risk of loss to follow up from unexpected early death . This has contributed to the lack of clear policy guidelines and resultant under-surveillance of breast cancer in elderly women.
A recent study with over 860,000 participants aged between 70–75 years has shown that breast cancer screening using mammography reduces deaths from the disease in women in this age group. This study also found that screening did not cause significant harm by exposing the older women to over-diagnosis and over-treatment . Numerous other investigations support targeted mammographic breast cancer screening in older age groups, [14–20] including a 2007 review  which found that there is now sufficient data to support regular screening above age 75 years based on individual assessment.
The size of the older population in Australia is growing, with females representing an increasing proportion of the population. At age 70, the average life expectancy of a woman living in Australia is over 15 years . Many of these women, if in sound health, will live considerably longer than the average life expectancy and will remain at risk for breast cancer development and recurrence. Approximately 25% of women 75 years of age will live more than 17 years and 50% will live at least another 12 years . There are approximately 56,000 female octogenarians currently living in Australia. This number is increasing and is predicted to reach approx 69,000 by 2020 and 107,000 by 2027 .
The existence of comorbid conditions has been used as rationale to exclude women over 69 years in breast cancer screening invitations. The findings of the most recent Australian Bureau of Statistics National Health Survey indicate that almost all people aged 65 years or older have at least one persistent health problem and around 80% reporting three or more . The most frequently reported long term conditions are problems with eyesight, hayfever/allergic rhinitis, arthritis and back and disc disorders [24, 25]. Considering the most commonly reported chronic conditions and the expected large heterogeneity in the health status of this older population, many women in older age groups will not have comorbidity severe enough to negate the benefits in survival and quality of life gained from breast cancer screening.
Research [26, 27] and projections  based on trends of improvements in health generally, including changing levels of fitness in all age groups, indicate that the total burden of chronic disease will decline significantly in the next three to four decades. Moreover, gerontological research has now identified factors that can predict which women are likely to remain in good health and which may not. For example, progressive dependence on others for support in daily living activities can predict reduced survival over the intermediate term [29–31].
The ability of elderly women to endure cancer treatment has been raised in the breast screening debate. Yet, less invasive surgical procedures and better targeting of breast cancer treatments strengthen support for the involvement of older women in breast cancer screening programs [32, 33]. A large body of evidence demonstrates that fit older women who have breast cancer can safely undergo the same treatments and show equal tolerance as their younger counterparts with comparable results. [34–40]
Resource limitation has also been given as a possible underlying reason for not encouraging routine screening older women. However, cost-effectiveness analyses suggest that breast cancer screening after the age of 65 years reduces mortality at reasonable costs in women who are without significant comorbidities and that it is likely to be worthwhile until a woman has an estimated life expectancy of between five and 10 years [41, 42]. Interventions to purposely foster participation in screening mammography among women 65 years and older are being researched internationally .
In 1997, Glasziou highlighted the importance of involving target groups in screening decisions in order to develop "rational and acceptable policy" around breast cancer screening . Breast Cancer Network Australia, a 22,000 member organisation, is the national organisation representing Australians affected by breast cancer. This group advocates for 'the availability of free mammography to be promoted to all women over 40, not just the target age of 50–69' . Similarly, Cancer Voices NSW, the independent, peak advocacy organisation for all people affected by cancer in New South Wales, with over 4,000 members, advocates for an increase in breast cancer screening promotion by government. Moreover, this organisation seeks for 'the adoption by government of the principles of cancer consumer participation wherever decisions affecting them are made' . The Breast Cancer Action Groups in NSW and Victoria have long advocated for screening reminders to be made available for women aged 70 and over .
The Australian community as a whole benefits from elderly members who are in good health and are given the opportunity to reach an average life expectancy at a minimum. Their contribution to childcare and other unpaid caring duties; financial, practical and emotional assistance to family members and friends, and voluntary work has been reported to add up to around 7% of the gross domestic product .
Overseas not-for-profit community support organisations also advocate for organised breast cancer screening for the elderly. The American Cancer Society advises women to continue breast cancer screening as long as they are in good health and are suitable candidates for cancer treatment  and the American Geriatrics Society [50, 51] recommends that screening should be individualised, rather than age-driven alone, recommending no upper age limit for screening, as long as estimated life expectancy is 4 years or more.
Detection of early stage breast cancers offers the potential for longer survival and enhanced quality of life for many women irrespective of age. There is a pressing need to assemble all relevant evidence, including community needs, with regard to breast cancer screening in the elderly and translate it into a cohesive policy.
We acknowledge that at policy level, making decisions around screening age is a complex process, but age alone should not be a criterion for discontinuing invitations to attend regular breast screening. Screening may not be suitable for all, as some women may have other health problems that would reduce the long-term benefit of screening or may choose not to screen for other reasons. For others, screening may provide some additional life years, that might otherwise be lost. Regardless of which position women take, the opportunity to weigh up the potential benefits and risks of mammography needs to be available to all if they so choose.
Decision-making aids, in conjunction with opportunities to discuss these decisions with their healthcare providers can assist women define their individual position around whether they wish to attend repeat screening. This information can be fed back to BreastScreen through an opt-off process, closing the loop on consumer involvement and improving public communication. Continuing the recall system, while providing realistic opportunities for women to examine benefit-harm tradeoffs would ensure that breast cancer screening remains equitable in all age groups and that beneficiaries can avail themselves of this service, fully informed of the consequences of their decisions.
With the growing number of older women in Australia, breast cancer will become an increasingly significant health concern, yet there is suboptimal surveillance of breast cancer in those aged over 69 years. Prompts to continue breast cancer screening are currently provided on the basis of chronological age alone. Continuing reminders after aged sixty nine and adopting a patient centred approach (which takes the form of an informed, shared, decision-making process between a woman and her medical practitioner) for individual decisions about screening is proposed.
The authors gratefully acknowledge the contribution of Dr Andrew Penman in providing comments and suggestions during the preparation of this paper.
- Australian Institute of Health and Welfare & National Breast Cancer Centre 2006: Breast cancer in Australia: an overview, 2006. Cancer series no. 34. cat. no. CAN 29. Canberra: AIHW, [http://www.aihw.gov.au/publications/can/bca06/bca06.pdf]
- Australian Institute of Health and Welfare 2008: BreastScreen Australia monitoring report 2004–2005. Cancer series no. 42. Cat. no. CAN 37. Canberra: AIHW, [http://www.aihw.gov.au/publications/can/bsamr04-05/bsamr04-05.pdf]
- Australian Bureau of Statistics 3303.0 – Causes of Death, Australia, 2006 Latest ISSUE 14/03/2008. [http://www.abs.gov.au/ausstats/abs@.nsf/0/2093DA6935DB138FCA2568A9001393C9]
- World Health Organization: The world health report 2000: health systems: improving performance. 2000, WHO, GenevaGoogle Scholar
- Gøtzsche PC, Nielsen M: Screening for breast cancer with mammography. Cochrane Database of Systematic Reviews. 2006, Art No. CD001877. DOI: 10.1002/14651858.CD001877.pub2 Date of last substantive update: July 12. 2006, [http://www.cochrane.org/reviews/en/ab001877.html]3View ArticleGoogle Scholar
- U. S. Preventive Services Task Force: Screening for breast cancer. 2008, Accessed Aug, 2008, [http://www.ahrq.gov/clinic/uspstf/uspsbrca.htm]Google Scholar
- Commonwealth Department of Health and Ageing: BreastScreen Australia Program. National Policy. [http://www.breastscreen.info.au/internet/screening/publishing.nsf/Content/national-policy]
- Bonfill X, Marzo M, Pladevall M, Martí J, Emparanza JI: Strategies for increasing the participation of women in community breast cancer screening. Cochrane Database of Systematic Reviews. 2001, Art No.: CD002943. DOI: 10.1002/14651858.CD002943, [http://www.cochrane.org/reviews/en/ab002943.html]1View ArticleGoogle Scholar
- Sarkeala T, Heinävaara S, Anttila A: Breast cancer mortality with varying invitational policies in organised mammography. British Journal of Cancer. 2008, 98: 641-645. 10.1038/sj.bjc.6604203. doi:10.1038/sj.bjc.6604203, [http://www.nature.com/bjc/journal/v98/n3/abs/6604203a.html]PubMed CentralView ArticlePubMedGoogle Scholar
- Commonwealth Department of Health and Ageing. BreastScreen Australia Program. Frequently asked questions. [http://www.breastscreen.info.au/internet/screening/publishing.nsf/Content/faqs#11]
- Australian Government Department of Health and Ageing. BreastScreen Australia Evaluation Progress and Status Report. 2008, [http://www.breastscreen.info.au/internet/screening/publishing.nsf/Content/97C27CCC0BAC1221CA2572D100205E1C/$File/progress-report-march-08.pdf]
- Bugeja G, Kumar A, Banerjee AK: Exclusion of elderly people from clinical research: a descriptive study of published reports. BMJ. 1997, 315: 1059-[http://www.bmj.com/cgi/content/full/315/7115/1059]PubMed CentralView ArticlePubMedGoogle Scholar
- Fracheboud J, de Gelder R, Draisma G, Otto SJ, Verbeek ALM, de Koning HJ: Is mammography screening effective up to 75 years?. European Journal of Cancer Supplements. 2008, 6 (7): 48-10.1016/S1359-6349(08)70317-3. [http://188.8.131.52/ciw-08ebcc/index.cfm?fuseaction=CIS2002&hoofdnav=Abstracts&content=abs.details&what=FREE%20TEXT&searchtext=fracheboud&topicselected=*&selection=ABSTRACT&qryStartRowDetail=1]View ArticleGoogle Scholar
- Randolph WM, Goodwin JS, Mahnken JD, et al: Regular mammography use is associated with elimination of age-related disparities in size and stage of breast cancer at diagnosis. Ann Intern Med. 2002, 137: 783-790.View ArticlePubMedGoogle Scholar
- Fracheboud Jacques, Groenewoud Helëne Johanna, Boer Rob, Draisma Gerrit, de Bruijn Arry, Verbeek André, de Koning Harry: Seventy-five years is an appropriate upper age limit for population-based mammography screening. International Journal of Cancer. 118 (8): 2020-2025. 10.1002/ijc.21560. [http://www.ncbi.nlm.nih.gov/pubmed/16287064]
- Otten JD, Broeders MJ, Fracheboud J, Otto SJ, de Koning HJ, Verbeek AL: Impressive time-related influence of the Dutch screening programme on breast cancer incidence and mortality, 1975–2006. Int J Cancer. 123 (8): 1929-34. 10.1002/ijc.23736. 2008 Oct 15, [http://www.ncbi.nlm.nih.gov/pubmed/18688863?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum]
- Broeders MJ, Verbeek AL, Straatman H, Peer PG, Jong PC, Beex LV, Hendriks JH, Holland R: Repeated mammographic screening reduces breast cancer mortality along the continuum of age. J Med Screen. 2002, 9 (4): 163-7. 10.1136/jms.9.4.163. [http://www.ncbi.nlm.nih.gov/pubmed/12518006?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum]View ArticlePubMedGoogle Scholar
- Badgwell BD, Giordano SH, Duan ZZ, Fang S, Bedrosian I, Kuerer HM, Singletary SE, Hunt KK, Hortobagyi GN, Babiera G: Mammography before diagnosis among women age 80 years and older with breast cancer. J Clin Oncol. 26 (15): 2482-8. 10.1200/JCO.2007.12.8058. 2008 May 20, [http://www.ncbi.nlm.nih.gov/pubmed/18427152?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum]
- Chen HH, Tabar L, Fagerberg G, et al: Effect of breast cancer screening after age 65. J Med Screen. 1995, 2: 10-14.PubMedGoogle Scholar
- Van Dijck JAAM, Verbeek ALM, Beex LVAM, et al: Mammographic screening after the age of 65 years: evidence for a reduction in breast cancer mortality. Int J Cancer. 1996, 66: 727-31. 10.1002/(SICI)1097-0215(19960611)66:6<727::AID-IJC3>3.0.CO;2-1.View ArticlePubMedGoogle Scholar
- Galit W, Green MS, Lital KB: Routine screening mammography in women older than 74 years: a review of the available data. Maturitas. 57 (2): 109-19. 10.1016/j.maturitas.2007.01.010. 2007 Jun 20; Epub 2007 Mar 1. Review, [http://www.ncbi.nlm.nih.gov/pubmed/17336004?ordinalpos=14&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum]
- Australian Bureau of Statistics: Year Book Australia, 2008 1301.0. Latest ISSUE Released 07/02/2008. [http://www.abs.gov.au/AUSSTATS/abs@.nsf/2f762f95845417aeca25706c00834efa/FF4D0275EFAC806FCA2573D2001101CE?opendocument]
- Australian Bureau of Statistics: Population Projections, Australia, 2004 to 2101 – 3222.0. Latest ISSUE Released 14/06/2006 Reissue. [http://www.abs.gov.au/AUSSTATS/abs@.nsf/ProductsbyCatalogue/5A9C0859C5F50C30CA25718C0015182F?OpenDocument]
- Australian Bureau of Statistics: National Health Survey: Summary of Results 2004–2005. 2006, Canberra: Commonwealth of Australia, [http://www.ausstats.abs.gov.au/Ausstats/subscriber.nsf/0/3B1917236618A042CA25711F00185526/$File/43640_2004-05.pdf]Google Scholar
- Australian Institute of Health and Welfare: Chronic diseases and associated risk factors in Australia, 2006. 2006, Canberra, ACTGoogle Scholar
- Khaw K: 'How many, how old, how soon?'. British Medical Journal. 1999, 319: 1350-2.PubMed CentralView ArticlePubMedGoogle Scholar
- Jacobzone S: 'Ageing and care for frail elderly persons: an overview of international perspectives'. OECD Labour Market and Social Policy Occasional Papers 38, OECD, Paris. 1999Google Scholar
- Singer B, Manton K: 'The effects of health changes on projections of health service needs for the elderly population of the United States'. Proceedings of the National Academy of Sciences. 1998, 95 (26): 15618-22. 10.1073/pnas.95.26.15618.View ArticleGoogle Scholar
- Wolinsky FD, Johnson RL, Stump TE: The Risk of Mortality Among Older Adults Over an Eight-Year Period. The Gerontol. 1995, 35: 150-61. [http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=7750771&dopt=AbstractPlus]View ArticleGoogle Scholar
- Dunlop DD, Hughes SL, Mannheim LM: Disability Patterns in Activities of Daily Living: Patterns of Change and a Hierarchy of Disability. Am J Publ Health. 1997, 87 (3): 378-83. 10.2105/AJPH.87.3.378. [http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=9096537]View ArticleGoogle Scholar
- Satariano WA, Ragland DR: The Effect of Co-Morbidity on 3-Year Survival of Women with Primary Breast Cancer. Ann Intern Med. 1994, 120: 104-110. [http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=8256968]View ArticlePubMedGoogle Scholar
- Veronesi U, Paganelli G, Viale G, Luini A, et al: randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med. 349 (6): 546-53. 10.1056/NEJMoa012782. [http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=12904519&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum]
- Goldhirsch A, Coates AS, Gelber RD, et al: First – select the target: better choice of adjuvant treatments for breast cancer patients. Ann Oncol. 2006, 17 (12): 1772-6. 10.1093/annonc/mdl398. Epub 2006 Oct 27, [http://www.ncbi.nlm.nih.gov/pubmed/17071934?dopt=Abstract]View ArticlePubMedGoogle Scholar
- Vlastos G, Mirza NQ, Meric F, et al: Breast conservation therapy as a treatment option for the elderly: The M.D. Anderson experience. Cancer. 2001, 92: 1092-1100. 10.1002/1097-0142(20010901)92:5<1092::AID-CNCR1425>3.0.CO;2-P.View ArticlePubMedGoogle Scholar
- Ibrahim NK, Buzdar AU, Asmar L, et al: Doxorubicin-based adjuvant chemotherapy in elderly breast cancer patients: The M.D. Anderson experience, with long-term follow-up. Ann Oncol. 2000, 11: 1597-1601. 10.1023/A:1008315312795.View ArticlePubMedGoogle Scholar
- Livi L, Paiar F, Saieva C, Simontacchi G, Nori J, Sanchez L, Santini R, Mangoni M, Fondelli S, Distante V, Bianchi S, Biti G: Breast cancer in the elderly: treatment of 1500 patients. Breast J. 2006, 12 (4): 353-9. 10.1111/j.1075-122X.2006.00275.x. [http://www.ncbi.nlm.nih.gov/pubmed/16848846?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum]View ArticlePubMedGoogle Scholar
- Holmes CE, Muss HB: Diagnosis and treatment of breast cancer in the elderly. CA Cancer J Clin. 2003, 53 (4): 227-44. Review, [http://www.ncbi.nlm.nih.gov/pubmed/12924776?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum]View ArticlePubMedGoogle Scholar
- Siebel MF, Muss HB: The influence of aging on the early detection, diagnosis, and treatment of breast cancer. Curr Oncol Rep. 2005, 7 (1): 23-30. 10.1007/s11912-005-0022-0. Review, [http://www.ncbi.nlm.nih.gov/pubmed/15610683?ordinalpos=2&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum]View ArticlePubMedGoogle Scholar
- Passage KJ, McCarthy NJ: Critical review of the management of early-stage breast cancer in elderly women. Intern Med J. 2007, 37 (3): 181-9. 10.1111/j.1445-5994.2007.01269.x. Review, [http://www.ncbi.nlm.nih.gov/pubmed/17316337?ordinalpos=23&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum]View ArticlePubMedGoogle Scholar
- Firvida JL, Vinolas N, Munoz M, Grau JJ, Daniels M, Estape A, Estape J: Age: a critical factor in cancer management. A prospective comparative study of 400 patients. Age and Ageing. 28: 103-105. 10.1093/ageing/28.2.103. [http://ageing.oxfordjournals.org/cgi/content/abstract/28/2/103]
- Mandelblatt J, Saha S, Teutsch S, Hoerger T, Siu AL, Atkins D, for the Cost Work Group of the U.S. Preventive Services Task Force, et al: The cost-effectiveness of screening mammography beyond age 65 years: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2003, 139: 835-42.View ArticlePubMedGoogle Scholar
- Barratt A, Irwig L, Glasziou P, et al: Benefits, harms and costs of screening mammography in women 70 years and over: a systematic review. MJA. 2002, 176 (6): 266-271.PubMedGoogle Scholar
- Michielutte R, Sharp PC, Foley KL, Cunningham LE, Spangler JG, Paskett ED, Case LD: Intervention to increase screening mammography among women 65 and older. Health Educ Res. 2005, 20: 149-162. 10.1093/her/cyg108.View ArticlePubMedGoogle Scholar
- Glasziou P, Irwig L: Mammographic screening in Australia Where are we, and where should we be going?. MJA. 1997, 167: 516-517. [http://www.mja.com.au/public/issues/nov17/glasziou/glasziou.html]PubMedGoogle Scholar
- Breast Cancer Network Australia: BreastScreen PositionStatement. 2008, [http://www.bcna.org.au/index.php?option=com_content&task=view&id=357&Itemid=356]Google Scholar
- Cancer Voices NSW: Election Wish List March 2007. Accessed June 2008, [http://www.cancervoices.org.au/]
- Breast Cancer Action Group NSW: Diagnosis and Treatment Position Paper, July 2007. Accessed December 2007, [http://www.bcagnsw.org.au/]
- De Vaus D, Gray M, Stanton D: Measuring the value of unpaid household, caring and voluntary work of older Australians, Australian Institute of Family Studies, Melbourne. 2003Google Scholar
- Smith RA, Cokkinides V, Eyre HJ: American Cancer Society guidelines for the early detection of cancer, 2004. CA Cancer J Clin. 2004, 54: 41-52.View ArticlePubMedGoogle Scholar
- The American Geriatrics Society: Health screening decisions for older adults. [http://www.americangeriatrics.org/products/poitionpapers/stopscreeningPF.shtml]
- The American Geriatrics Society: Position statement: breast cancer screening in older women. [http://www.americangeriatrics.org/staging/products/poitionpapers/brstcncrPF.shtml]
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.